FinnCap reiterated their corporate rating on shares of Yourgene Health (LON:YGEN) in a report released on Monday morning.
YGEN stock opened at GBX 13.25 ($0.17) on Monday.
About Yourgene Health
Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Featured Story: How Buying a Call Option Works
Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.